Analysis of the Correlation Between Membrane Permeability in RPMI 2650 Cells and Human Nasal Absorption
- 10 February 2026
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (2) , 96
Abstract
Nasal drug delivery offers several advantages, such as rapid onset and avoidance of hepatic first-pass metabolism, making it a promising option for deliverKeywords
This publication has 64 references indexed in Scilit:
- Characterization of critical parameters using an air–liquid interface model with RPMI 2650 cells for permeability studies of small moleculesDrug Delivery and Translational Research, 2023
- In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug deliveryBiopharmaceutics & Drug Disposition, 2023
- Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future NeedsCNS Drugs, 2022
- Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?European Journal of Drug Metabolism and Pharmacokinetics, 2017
- The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal ModelPharmaceutical Research, 2014
- Transporter‐Mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to TargetMolecular Informatics, 2010
- Characterization of lidocaine metabolism by rat nasal microsomes: implications for nasal drug deliveryEuropean Journal of Drug Metabolism and Pharmacokinetics, 1999
- Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled AdministrationThe Journal of Clinical Pharmacology, 1995
- Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administrationEuropean Journal of Clinical Pharmacology, 1989
- Nasal absorption of propranolol in humansJournal of Pharmaceutical Sciences, 1980